C-Reactive Protein is the Main Factor for Prediction of Fatigue in Preeclampsia Women

Hanan Jasim

doi:10.31185/wjps.553

Authors

Hanan Jasim Alomahi Wasit Water Directorate

DOI:

https://doi.org/10.31185/wjps.553

Abstract

Preeclampsia is associated with many neuropsychiatric symptoms including fatigue. Many biomarkers are correlated with fibro fatigue (FF) scores. The present study aims to examine the changes in the advanced-glycated end-products (AGEs) and its receptor (RAGE), Vascular endothelial growth factor (VEGF) and its receptor (VEGFR1), C-reactive protein (CRP) and lipid profile and atherogenic indices in preeclampsia as predictors for preeclampsia patients with higher FF score. Preeclampsia patients were divided according to the FF score into high-FF (FF≥25) and low-FF (FF<25). The biomarkers and FF scores were measured in the patient groups and compared with healthy pregnant controls. PE women had higher levels of AGEs, RAGE, VEGF, and VEGFR1 than control women, and the rise is greater in the high-FF PE group compared with the low-FF group. PE women also have dyslipidemia and low-grade inflammation (high serum CRP), which rise with FF score. The multivariate generalized linear model (GLM) analysis showed no significant effect of the covariates (age, gestational age, gravidity, age of onset, and duration of PE) on the measured biomarkers. The study found significant differences in all parameters for high-FF PE patients (Partial η² = 0.727). CRP is the only receiver-operating characteristics (ROC) variable distinguishing high-FF PE women from low-FF PE women. The high-FF scores in PE are related to the lipid profile and atherogenic indices as well as dyslipidemia and low-grade inflammation. PE patients with high-FF can be significantly predicted by high-CRP levels.

References

N. A. Bello et al., "Prevalence of hypertension among pregnant women when using the 2017 American College of Cardiology/American Heart Association blood pressure guidelines and association with maternal and fetal outcomes," JAMA Network Open, vol. 4, no. 3, pp. e213808-e213808, 2021.

E. O. Anto et al., "Prevalence of preeclampsia and algorithm of adverse foeto-maternal risk factors among pregnant women in the Central Region of Ghana: A multicentre prospective cross-sectional study," PLoS One, vol. 18, no. 6, p. e0288079, 2023.

V. Shandilya, N. Sinha, and S. Rani, "Preeclampsia: Prevalence, Risk Factors, and Impact on Mother and Fetus," Indian Journal of Cardiovascular Disease in Women, vol. 8, no. 3, pp. 193-199, 2023.

A. C. Westerberg, M.-H. L. Degnes, I. J. Andresen, M. C. P. Roland, and T. M. Michelsen, "Angiogenic and vasoactive proteins in the maternal-fetal interface in healthy pregnancies and preeclampsia," American Journal of Obstetrics Gynecology, 2024.

E. Roes, R. Sieben, M. Raijmakers, W. Peters, and E. J. H. i. p. Steegers, "Severe preeclampsia is associated with a positive family history of hypertension and hypercholesterolemia," Hypertension in Pregnancy, vol. 24, no. 3, pp. 259-271, 2005.

V. I. Ashchepkova et al., "Neurology of Preeclampsia and Related Diseases: A Literary Review," Archives of Pharmacy Practice, vol. 15, no. 3-2024, pp. 37-42, 2024.

P. M. Mommersteeg, J. T. Drost, J. P. Ottervanger, and A. H. Maas, "Long-term follow-up of psychosocial distress after early onset preeclampsia: the Preeclampsia Risk EValuation in FEMales cohort study," (in eng), J Psychosom Obstet Gynaecol, vol. 37, no. 3, pp. 101-9, Sep 2016.

C. Y. Cheng, Y. H. Chou, P. Wang, J. M. Tsai, and S. R. Liou, "Survey of trend and factors in perinatal maternal fatigue," (in eng), Nurs Health Sci, vol. 17, no. 1, pp. 64-70, Mar 2015.

S. E. Maynard and S. A. Karumanchi, "Angiogenic factors and preeclampsia," in Seminars in nephrology, 2011, vol. 31, no. 1, pp. 33-46: Elsevier.

N. Ferrara, "Vascular endothelial growth factor: basic science and clinical progress," Endocrine reviews, vol. 25, no. 4, pp. 581-611, 2004.

F. Bayor, "Maternal Serum Angiopoietin And Vascular Endothelial Growth Factor (Vegf) Levels In Preeclampsia And Pregnancy Outcomes," University Of Ghana, 2021.

R. J. Levine et al., "Circulating angiogenic factors and the risk of preeclampsia," New England Journal of Medicine, vol. 350, no. 7, pp. 672-683, 2004.

M. Yang, M. Wang, and N. Li, "Advances in pathogenesis of preeclampsia," Archives of Gynecology Obstetrics, vol. 309, no. 5, pp. 1815-1823, 2024.

M. L. Mancini, A. Terzic, B. A. Conley, L. H. Oxburgh, T. Nicola, and C. P. Vary, "Endoglin plays distinct roles in vascular smooth muscle cell recruitment and regulation of arteriovenous identity during angiogenesis," Developmental Dynamics, vol. 238, no. 10, pp. 2479-2493, 2009.

G. Margioula-Siarkou et al., "The role of endoglin and its soluble form in pathogenesis of preeclampsia," (in eng), Mol Cell Biochem, vol. 477, no. 2, pp. 479-491, Feb 2022.

M. J. Schmella et al., "Plasma concentrations of soluble endoglin in the maternal circulation are associated with maternal vascular malperfusion lesions in the placenta of women with preeclampsia," Placenta, vol. 78, pp. 29-35, 2019.

A. Sakarde, J. John, A. K. Ahirwar, and V. Hardas, "Serum Lipid Profile Parameters as Markers of Oxidative Stress in Preeclampsia-A Case-control Study," Nat Journal of Lab Med, vol. 11, pp. B025-9, 2022.

C. Punthumapol and B. Kittichotpanich, "Comparative study of serum lipid concentrations in preeclampsia and normal pregnancy," J Med Assoc Thai, vol. 91, no. 7, pp. 957-61, 2008.

Y. Wang, D. Shi, and L. Chen, "Lipid profile and cytokines in hypertension of pregnancy: A comparison of preeclampsia therapies," The Journal of Clinical Hypertension, vol. 20, no. 2, pp. 394-399, 2018.

R. Elazab, M. Alkhiary, M. Bedairi, and A. Wageh, "Simultaneous use of Tumor Necrosis Factor, Lipid Profile, and β-hCG As Markers of Severity of Preeclampsia," (in eng), J Obstet Gynaecol India, vol. 72, no. Suppl 1, pp. 83-88, Aug 2022.

K. Winkler et al., "Triglyceride-rich lipoproteins are associated with hypertension in preeclampsia," (in eng), J Clin Endocrinol Metab, vol. 88, no. 3, pp. 1162-6, Mar 2003.

T. I. Alahakoon, H. J. Medbury, H. Williams, and V. W. Lee, "Lipid profiling in maternal and fetal circulations in preeclampsia and fetal growth restriction-a prospective case control observational study," (in eng), BMC Pregnancy Childbirth, vol. 20, no. 1, p. 61, Jan 30 2020.

K. Prasad, "Low levels of serum soluble receptors for advanced glycation end products, biomarkers for disease state: myth or reality," (in eng), Int J Angiol, vol. 23, no. 1, pp. 11-6, Mar 2014.

Q. Xie, L. Ma, Z. Xiao, M. Yang, M. J. J. o. D. Chen, and i. Complications, "Role of profilin-1 in vasculopathy induced by advanced glycation end products (AGEs)," vol. 37, no. 5, p. 108415, 2023.

H. Matsumoto et al., "The clinical significance of circulating soluble RAGE in patients with severe sepsis," (in eng), J Trauma Acute Care Surg, vol. 78, no. 6, pp. 1086-93; discussion 1093-4, Jun 2015.

K. Taguchi and K. Fukami, "RAGE signaling regulates the progression of diabetic complications," Frontiers in Pharmacology, vol. 14, p. 704, 2023.

K. L. Alexander et al., "Differential Receptor for Advanced Glycation End Products Expression in Preeclamptic, Intrauterine Growth Restricted, and Gestational Diabetic Placentas," (in eng), Am J Reprod Immunol, vol. 75, no. 2, pp. 172-80, Feb 2016.

A. Lou et al., "Advanced oxidation protein products induce inflammatory responses and invasive behaviour in fibroblast-like synoviocytes via the RAGE-NF-κB pathway," (in eng), Bone Joint Res, vol. 10, no. 4, pp. 259-268, Apr 2021.

S. Krishnasamy et al., "Association of advanced glycation end products (AGEs) with endothelial dysfunction, oxidative stress in gestational diabetes mellitus (GDM)," International Journal of Diabetes in Developing Countries, vol. 40, pp. 276-282, 2020.

E. Kintiraki, S. Papakatsika, G. Kotronis, D. G. Goulis, and V. Kotsis, "Pregnancy-Induced hypertension," (in eng), Hormones (Athens), vol. 14, no. 2, pp. 211-23, Apr-Jun 2015.

M. Csongová et al., "The effects of a maternal advanced glycation end product-rich diet on somatic features, reflex ontogeny and metabolic parameters of offspring mice," (in eng), Food Funct, vol. 9, no. 6, pp. 3432-3446, Jun 20 2018.

N. K. Harsem, K. Braekke, T. Torjussen, K. Hanssen, and A. C. Staff, "Advanced glycation end products in pregnancies complicated with diabetes mellitus or preeclampsia," (in eng), Hypertens Pregnancy, vol. 27, no. 4, pp. 374-86, 2008.

O. Zachrisson, B. Regland, M. Jahreskog, M. Kron, and C. G. Gottfries, "A rating scale for fibromyalgia and chronic fatigue syndrome (the FibroFatigue scale)," Journal of Psychosomatic Research, vol. 52, no. 6, pp. 501-509, 2002.

W. T. M. Al Masoodi, S. W. Radhi, H. K. Al-Hakeim, and H. K. Abdalsada, "Electrolytes as predictors of fibro fatigue scores in Long-COVID patients," Plos one, vol. 19, no. 8, p. e0309348, 2024.

E. M. Roes, M. T. Raijmakers, M. Schoonenberg, N. Wanner, W. H. Peters, and E. A. Steegers, "Physical well-being in women with a history of severe preeclampsia," The Journal of Maternal-Fetal Neonatal Medicine, vol. 18, no. 1, pp. 39-45, 2005.

N. O. Enaruna, J. O. Idemudia, and P. I. Aikoriogie, "Serum lipid profile and uric acid levels in preeclampsia in University of Benin Teaching Hospital," (in eng), Niger Med J, vol. 55, no. 5, pp. 423-7, Sep 2014.

P. Kumari, M. Chouhan, B. Jakhar, and G. Sharma, "A comparative study of serum lipid profile in preeclampsia and normotensive pregnancy in third trimester and their fetomaternal outcome," International Journal of Reproduction, Contraception, Obstetrics Gynecology, vol. 12, no. 7, p. 2178, 2023.

U. Salma, "Relationship of serum lipid profiles in preeclampsia and normal pregnancy, Bangladesh," (in eng), Afr Health Sci, vol. 22, no. 2, pp. 475-479, Jun 2022.

F. D. H. Olalere, B. O. Okusanya, and B. A. Oye-Adeniran, "Maternal serum lipid in women with preeclampsia in Lagos: a case control study," (in eng), J Matern Fetal Neonatal Med, vol. 33, no. 5, pp. 794-798, Mar 2020.

M. Rana, M. A. Cheema, R. A. Khan, A. Kanwal, A. M. Rana, and K. P. Lone, "Serum resistin and lipid profile in primigravida females with and without preeclampsia: An analytical cross-sectional study," (in eng), J Pak Med Assoc, vol. 74, no. 1, pp. 62-66, Jan 2024.

J. S. Possomato-Vieira and R. A. Khalil, "Mechanisms of endothelial dysfunction in hypertensive pregnancy and preeclampsia," in Advances in pharmacology, vol. 77: Elsevier, 2016, pp. 361-431.

E. M. Maloney, R. S. Boneva, J.-M. S. Lin, and W. C. Reeves, "Chronic fatigue syndrome is associated with metabolic syndrome: results from a case-control study in Georgia," Metabolism, vol. 59, no. 9, pp. 1351-1357, 2010/09/01/ 2010.

M. J. Kupferminc et al., "Vascular endothelial growth factor is increased in patients with preeclampsia," American Journal of Reproductive Immunology, vol. 38, no. 4, pp. 302-306, 1997.

V. Tandon, S. Hiwale, D. Amle, T. Nagaria, and P. K. Patra, "Assessment of Serum Vascular Endothelial Growth Factor Levels in Pregnancy-Induced Hypertension Patients," Journal of Pregnancy, vol. 2017, no. 1, p. 3179670, 2017.

R. J. Levine et al., "Soluble endoglin and other circulating antiangiogenic factors in preeclampsia," New England Journal of Medicine, vol. 355, no. 10, pp. 992-1005, 2006.

V. Pant, B. K. Yadav, and J. Sharma, "A cross sectional study to assess the sFlt-1:PlGF ratio in pregnant women with and without preeclampsia," BMC Pregnancy and Childbirth, vol. 19, no. 1, p. 266, 2019/07/25 2019.

F. F. Khidri et al., "Vascular endothelial growth factor/platelet ratio as a potential biomarker for preeclampsia: A study of angiogenic markers in Pakistani patients," Obstetric Medicine, vol. 0, no. 0, p. 1753495X241234961, 2024.

S. E. Maynard et al., "Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia," The Journal of clinical investigation, vol. 111, no. 5, pp. 649-658, 2003.

D. Mihu, C. Razvan, A. Malutan, and C. Mihaela, "Evaluation of maternal systemic inflammatory response in preeclampsia," Taiwanese Journal of Obstetrics and Gynecology, vol. 54, no. 2, pp. 160-166, 2015/04/01/ 2015.

D. C. Cornelius, "Preeclampsia: From Inflammation to Immunoregulation," Clinical Medicine Insights: Blood Disorders, vol. 11, p. 1179545X17752325, 2018/01/01 2018.

V. Tsatsaris et al., "Overexpression of the soluble vascular endothelial growth factor receptor in preeclamptic patients: pathophysiological consequences," The Journal of Clinical Endocrinology Metabolism, vol. 88, no. 11, pp. 5555-5563, 2003.

A. De Vivo, G. Baviera, D. Giordano, G. Todarello, F. Corrado, and R. J. A. o. e. g. S. D'anna, "Endoglin, PlGF and sFlt-1 as markers for predicting pre-eclampsia," Acta Obstetricia et Gynecologica Scandinavica, vol. 87, no. 8, pp. 837-842, 2008.

G. Margioula-Siarkou et al., "Soluble endoglin concentration in maternal blood as a diagnostic biomarker of preeclampsia: A systematic review and meta-analysis," European Journal of Obstetrics Gynecology Reproductive Biology, vol. 258, pp. 366-381, 2021.

H. Tian et al., "Endoglin interacts with VEGFR2 to promote angiogenesis," The FASEB Journal, vol. 32, no. 6, pp. 2934-2949, 2018.

S. Park, C. M. Sorenson, and N. Sheibani, "PECAM-1 isoforms, eNOS and endoglin axis in regulation of angiogenesis," Clinical science, vol. 129, no. 3, pp. 217-234, 2015.

A. M. Blázquez-Medela et al., "Increased plasma soluble endoglin levels as an indicator of cardiovascular alterations in hypertensive and diabetic patients," (in eng), BMC Med, vol. 8, p. 86, Dec 20 2010.

S. Venkatesha et al., "Soluble endoglin contributes to the pathogenesis of preeclampsia," (in eng), Nat Med, vol. 12, no. 6, pp. 642-9, Jun 2006.

T. K. Njoku et al., "Serum lipid profiles in preeclamptic versus normotensive pregnancies: A case-control study," Journal of Pediatrics, Perinatology Child Health, vol. 8, no. 3, pp. 105-114, 2024.

N. R. Hart, "Paradoxes: Cholesterol and Hypoxia in Preeclampsia," Biomolecules, vol. 14, no. 6, p. 691, 2024.

N. E. Poveda et al., "Triglycerides/glucose and triglyceride/high‐density lipoprotein cholesterol indices in normal and preeclamptic pregnancies: A longitudinal study," International journal of endocrinology, vol. 2018, no. 1, p. 8956404, 2018.

C. N. Spracklen, C. J. Smith, A. F. Saftlas, J. G. Robinson, and K. K. Ryckman, "Maternal hyperlipidemia and the risk of preeclampsia: a meta-analysis," American journal of epidemiology, vol. 180, no. 4, pp. 346-358, 2014.

M. Jerkic et al., "Endoglin regulates nitric oxide-dependent vasodilatation," (in eng), Faseb j, vol. 18, no. 3, pp. 609-11, Mar 2004.

C.-L. Yang, C.-Y. J. M. Chang, and C. H. Journal, "Fatigue during pregnancy: a bibliometric analysis," Maternal Child Health Journal, vol. 27, no. 5, pp. 766-773, 2023.

K. Pankiewicz, E. Szczerba, T. Maciejewski, and A. Fijałkowska, "Non-obstetric complications in preeclampsia," Menopause Review, vol. 18, no. 2, pp. 99-109, 2019.

J. Roberts and D. W. Cooper, "Pathogenesis and genetics of pre-eclampsia," The Lancet, vol. 357, no. 9249, pp. 53-56, 2001.

N. Charles, N. Amarachukwu, E. Ekpo, and E. Cajethan, "Changes in renal function among women with preeclampsia in a tertiary health institution in Nigeria," Int J Womens Health Rep Sci, vol. 8, no. 3, pp. 272-275, 2020.

M. I. Khattak, S. N. Khattak, U. Yaqub, A. Imran, K. Kamal, and J. Liaqat, "Spectrum of Electrolytes in Pre-eclampsia; A Case Controlled Study," Journal of The Society of Obstetricians Gynaecologists of Pakistan, vol. 11, no. 2, pp. 100-105, 2021.

K. D. Black, "Stress, symptoms, self‐monitoring confidence, well‐being, and social support in the progression of preeclampsia/gestational hypertension," Journal of Obstetric, Gynecologic Neonatal Nursing, vol. 36, no. 5, pp. 419-429, 2007.

O. Cetin, P. Guzel Ozdemir, Z. Kurdoglu, and H. G. Sahin, "Investigation of maternal psychopathological symptoms, dream anxiety and insomnia in preeclampsia," The Journal of Maternal-Fetal Neonatal Medicine, vol. 30, no. 20, pp. 2510-2515, 2017.

O. Abdel-Wahab Afifi Araby Ali, F. Kamal Ali, A. Mohamed Salama, and F. Mansour Abdel Azeem Barakat, "Effect of Progressive Muscle Relaxation Techniques on Physiological Parameters, Psychological Factors and Sleep Quality among Pregnant Women with Preeclampsia," Egyptian Journal of Health Care, vol. 15, no. 2, pp. 125-148, 2024.